,outcome,arm 1,arm 2
0,intervention,topotecan group,paclitaxel
0,,18.9 weeks ( range < 1 to 92.6+ weeks,NR
0,median time to progression,NR,14.7 weeks ( range < 1 to 137.3+ weeks ; 12.3 % censored )
